A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

Clinical trial NCT07355062 · RECRUITING

Trial details

NCT number: NCT07355062
Sponsor: Renibus Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

CKD Metabolic Acidosis

Start date: 2026-01-13
Primary completion: 2027-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.